UNDERWRITING AGREEMENT 22,300,000 Common Shares AURINIA PHARMACEUTICALS INC. (incorporated under the Business Corporations Act (Alberta))Underwriting Agreement • March 16th, 2017 • Aurinia Pharmaceuticals Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 16th, 2017 Company Industry JurisdictionAurinia Pharmaceuticals Inc., a company incorporated under the Business Corporations Act (Alberta) (the “Company”), proposes to sell to the several underwriters named in Schedule I hereto (the “Underwriters”) for whom Leerink Partners LLC (“Leerink”) and Cantor Fitzgerald & Co. are acting as the representatives (the “Representatives”), an aggregate of 22,300,000 common shares (each, a “Firm Share”), no par value, of the Company (the “Common Shares”). The Company also proposes to grant to the Underwriters an option to purchase up to 3,345,000 additional Common Shares (the “Option Shares” and, together with the Firm Shares, the “Shares”).